NFKB1 and cancer: By inhibiting pro-apoptotic proteins like caspases and promoting anti-apoptotic proteins such as the FLICE-like inhibitory protein (c-FLIP) and inhibitors of apoptosis proteins (IAPs), NF-κB renders cancer cells more resistant to cell death and, consequently, to various chemotherapeutic agents [106].